Broadmeadows teen Sogol Moradi was told at age 11 that a tumour growing behind her eye was affecting her vision.
For patients with NF2-related schwannomatosis and progressive tumors, the ALK inhibitor brigatinib (Alunbrig) was associated with radiographic response for multiple tumor types, as well as ...
N2M2/NOA-20: Phase I/IIa umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation. This is an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results